UBC PiMS Research Group (the Tremlett Laboratory)
Pharmacoepidemiology in Multiple Sclerosis Research Group (the Tremlett Laboratory)

Natural Improvements in MS are Possible

Multiple sclerosis (MS) patients sometimes experience “natural” improvements in disability.

Elaine Kingwell’s study featured on MSology.ca

Cancer risk lower in people with MS

Afsaneh Shirani’s New Beta Interferon Study published in JAMA

Beta Interferon not associated with reducing Long-Term disease progression in patients with relapsing remitting MS

Elaine Kingwell’s Cancer and MS Study is Published in Brain

Multiple sclerosis patients appear to have a lower cancer risk.

New video showcases the UBC PIMS team


Relative mortality and survival in multiple sclerosis: Findings from British Columbia

Elaine Kingwell recently had her study published in the Journal of Neurology, Neurosurgery & Psychiatry.

Temporal trends of disability progression in multiple sclerosis

Afsaneh Shirani’s Paper was recently published in the Multiple Sclerosis Journal.

Perinatal outcomes in women with multiple sclerosis exposed to disease-modifying drugs

UBC PhD Candidate, Ellen Lu, published her findings in the Multiple Sclerosis Journal (2012).

Neonatal and delivery outcomes in women with multiple sclerosis

Mia van der Kop’s recent study was featured on mssociety.ca.

a place of mind, The University of British Columbia

Pharmacoepidemiology in MS (PiMS)
2211 Wesbrook Mall,
Vancouver, BC, V6T 2B5, Canada

Emergency Procedures | Accessibility | Contact UBC  | © Copyright The University of British Columbia